Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/2012

Open Access 01-12-2012 | Poster presentation

IL-17-producing ©™T cells are important for the development of arthritis in a rheumatoid arthritis model

Authors: Aoi Akitsu, Harumichi Ishigame, Shigeru Kakuta, Shinobu Saijo, Yoichiro Iwakura

Published in: Arthritis Research & Therapy | Special Issue 1/2012

Login to get access

Excerpt

IL-1 receptor antagonist deficient (Il1rn-/-) mice spontaneously develop arthritis. We previously demonstrated that IL-17 plays a crucial role in the development of arthritis in Il1rn-/- mice. Furthermore we showed that IL-1 Ra-deficiency in T cells is important for the development of arthritis. It is not known, however, which IL-17-producing cells are involved in the pathogenesis of arthritis in this model. …
Metadata
Title
IL-17-producing ©™T cells are important for the development of arthritis in a rheumatoid arthritis model
Authors
Aoi Akitsu
Harumichi Ishigame
Shigeru Kakuta
Shinobu Saijo
Yoichiro Iwakura
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue Special Issue 1/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3604

Other articles of this Special Issue 1/2012

Arthritis Research & Therapy 1/2012 Go to the issue

Poster presentation

MiRs in RA: possible biomarkers and therapeutic targets

Poster presentation

Features of rheumatic fever in adult patients in modern Kyrgyzstan

Poster presentation

Expression patterns and function of chromatin protein HMGB2 during mesenchymal stem cell differentiation

Oral presentation

Abnormal osteogenesis in osteoarthritis: gone with the Wnt?

Oral presentation

A systems approach reveals that the musculoskeletal tissues development and homeostasis network

Poster presentation

Community-based epidemiological study on hyperuricemia and gout over 5 years in Huang-pu district, Shanghai
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits